Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Cancer Research|November 13, 2003
The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathwayHeng Qi, Michael OhhMethods in Molecular Biology (Clifton, N.J.)|November 25, 2011
Transcriptional regulation of genes via hypoxia-inducible factorOlga Roche, Michael OhhMethods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL)Pardeep Heir, Michael OhhJournal of Cellular and Molecular Medicine|January 20, 2010
Oxygen-mediated endocytosis in cancerYi Wang, Michael OhhCurrent Opinion in Oncology|November 29, 2007
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-LindauAndrew M Roberts, Michael OhhNeoplasia (New York, N.Y.)|November 30, 2006
Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complexRoxana I Sufan, Michael OhhCell Cycle (Georgetown, Tex.)|January 25, 2007
The role of VHL in the regulation of E-cadherin: a new connection in an old pathwayRyan C Russell, Michael OhhFEBS Letters|March 4, 2014
The multifaceted von Hippel-Lindau tumour suppressor proteinClaire M Robinson, Michael OhhPageof 8